West Chester-based Verrica Pharmaceuticals is expecting to raise $32.5 million from the sale of 750,000 shares of its common stock at $6…

West Chester’s Verrica Pharmaceuticals is seeking FDA approval to market the drug “Ycanth,” which treats a skin condition, writes John George for the Philadelphia…

Malvern-based biopharmaceutical company Galera Therapeutics is filing for FDA approval of a new drug. The treatment, avasopasem, helps radiotherapy-induced severe oral mucositis, or…

Malvern-based Ocugen has submitted a request to the Food and Drug Administration for Emergency Use Authorization (EUA) of its COVID-19 vaccine candidate for…

A new study by the Centers for Disease Control and Prevention (CDC) found the Pfizer COVID-19 vaccine to be 93 percent effective in protecting…

Melior Pharmaceuticals, an Exton-based company that specializes in repositioning old medicines for new uses, has been given the green light by the FDA to…

West Chester-based Verrica Pharmaceuticals saw its stock plunge by nearly 22 percent after the FDA voiced concerns about its lead drug candidate, VP-102…

Devon-based Zynerba Pharmaceuticals has received “Fast Track” status from the FDA for its synthetic cannabidiol drug intended to treat symptoms associated with Fragile X…

If approved by the FDA to treat post-traumatic stress disorder, MDMA – the party drug known as “Molly” or “ecstasy” – will be prepared for shipping…

The rampant drug abuse linked to a Malvern-based opioid pain medication has led to the U.S. Food and Drug Administration’s first-ever…